ST. LOUIS, July 11, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its second quarter earnings on Monday, July 25, 2016 after the market closes and will hold its quarterly conference call to discuss second quarter results on Tuesday, July 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

This call is being webcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.

A slide presentation will also be posted on Express Scripts’ website. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts’ website for 14 days.

About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

Contact Information:
Eric Slusser, Chief Financial Officer
Ben Bier, Vice President, Investor Relations
(314) 810-3115
Investor.relations@express-scripts.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.